根据最新的财务报表(Form-10K),CSPC Pharmaceutical Group Limited 的总资产为 $0,净亏损为 $0
CSPCY 的关键财务比率是什么?
CSPC Pharmaceutical Group Limited 的流动比率是 0,净利 margin 为 0,每股销售为 $0。
CSPC Pharmaceutical Group Limited 的收入按细分市场或地理位置如何划分?
CSPC Pharmaceutical Group Limited 最大收入来源是 Total Finished Drugs,在最近的收益报告中收入为 17,937,001,000。就地区而言, Mainland China 是 CSPC Pharmaceutical Group Limited 的主要市场,收入为 20,825,921,000。
CSPC Pharmaceutical Group Limited 是否盈利?
否,根据最新的财务报表,CSPC Pharmaceutical Group Limited 的净亏损为 $0
CSPC Pharmaceutical Group Limited 有负债吗?
否,CSPC Pharmaceutical Group Limited 的负债为 0
CSPC Pharmaceutical Group Limited 的流通股有多少?
CSPC Pharmaceutical Group Limited 的总流通股为 0
关键数据
前收盘价
$3.42
开盘价
$3.37
当日区间
$3.36 - $3.37
52周范围
$3.36 - $5.83
交易量
124
平均成交量
2.3K
股息收益率
--
每股收益(TTM)
0.20
市值
$9.5B
什么是 CSPC Pharmaceuticals Group Ltd.?
CSPC Pharmaceutical Group Ltd. is an investment holding company, which is engaged in the manufacturing and selling of pharmaceutical products. The company is headquartered in Shijiazhuang, Hebei and currently employs 19,700 full-time employees. The firm's main businesses include finished drug manufacturing, bulk product business, functional food and other businesses. The firm's products mainly cover the nervous system, anti-tumor, anti-infective, cardiovascular, respiratory system, digestive and metabolic, and other therapeutic areas. The firm conducts its businesses in domestic and overseas markets.